An increase in TMAO levels leads to the accumulation of amyloid-beta (Aβ) peptides and hyperphosphorylated tau protein (p-tau) in neuronal cells, representing a major pathogenic mechanism in AD patients (William, 2010). This evidence concerns the gene MAPT and Alzheimer disease.